• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蒙特利尔认知评估作为精神分裂症认知障碍的筛查工具。

Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia.

机构信息

Research Division, Institute of Mental Health, Singapore, Singapore.

Research Division, Institute of Mental Health, Singapore, Singapore.

出版信息

Schizophr Res. 2018 Sep;199:58-63. doi: 10.1016/j.schres.2018.03.008. Epub 2018 Mar 14.

DOI:10.1016/j.schres.2018.03.008
PMID:29549976
Abstract

BACKGROUND

Cognitive impairment is one of the core features of schizophrenia. For its evaluation, current clinical practice relies on detailed neuropsychological batteries which require trained testers and considerable amount of time to administer. Therefore, a brief and reliable screening tool for identification of overall cognitive impairment prior to a detailed comprehensive neurocognitive assessment is needed in a busy clinical setting. This study evaluates the clinical utility of the Montreal Cognitive Assessment (MoCA) in detecting cognitive impairments in schizophrenia and its relationship with functional outcome and demographic characters.

METHODS

The MoCA, the Brief Assessment of Cognition in Schizophrenia (BACS), and the Brief UCSD Performance-based Skills Assessment (UPSA-B) were administered to 64 patients with schizophrenia. Mild and severe cognitive impairments were defined as BACS Z-score (calculated with the age and gender adjustments using previously published local norm data) of one or two standard deviations below the mean, respectively.

RESULTS

The results showed that the MoCA was significantly correlated with BACS (r=.61, p<.001) and sensitive to detect both mild (AUC=0.82, p<.001) and severe (AUC=0.81, p<.001) cognitive impairments in schizophrenia. The MoCA was significantly correlated with UPSA-B score (r=.51, p<.001), and accounted for significant additional variance in UPSA-B score beyond the BACS.

CONCLUSION

These findings indicate that MoCA is a useful bedside cognitive screening instrument for people with schizophrenia.

摘要

背景

认知障碍是精神分裂症的核心特征之一。目前的临床实践评估认知功能依赖于详细的神经心理学测试,这些测试需要经过培训的测试人员,并需要大量的时间来进行。因此,在繁忙的临床环境中,需要一种简短而可靠的筛查工具,以便在进行详细的全面认知评估之前,确定总体认知障碍。本研究评估了蒙特利尔认知评估(MoCA)在检测精神分裂症认知障碍方面的临床效用,及其与功能结局和人口统计学特征的关系。

方法

对 64 名精神分裂症患者进行了 MoCA、简短认知评估精神分裂症量表(BACS)和简短 UCSD 基于表现的技能评估(UPSA-B)的评估。轻度和重度认知障碍定义为 BACS Z 分数(使用先前发表的本地正常数据进行年龄和性别调整后计算)低于平均值一个或两个标准差。

结果

结果表明,MoCA 与 BACS 显著相关(r=.61,p<.001),能够敏感地检测精神分裂症中的轻度(AUC=0.82,p<.001)和重度(AUC=0.81,p<.001)认知障碍。MoCA 与 UPSA-B 评分显著相关(r=.51,p<.001),并且在 UPSA-B 评分中,除了 BACS 之外,还解释了显著的额外方差。

结论

这些发现表明,MoCA 是一种有用的精神分裂症患者床边认知筛查工具。

相似文献

1
Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia.蒙特利尔认知评估作为精神分裂症认知障碍的筛查工具。
Schizophr Res. 2018 Sep;199:58-63. doi: 10.1016/j.schres.2018.03.008. Epub 2018 Mar 14.
2
The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.使用蒙特利尔认知评估(MoCA)筛查工具评估黎巴嫩住院精神分裂症患者的认知缺陷。
Asian J Psychiatr. 2022 Apr;70:103029. doi: 10.1016/j.ajp.2022.103029. Epub 2022 Feb 13.
3
Investigation of the Montreal Cognitive Assessment (MoCA) as a cognitive screener in severe mental illness.蒙特利尔认知评估(MoCA)作为严重精神疾病认知筛查工具的研究。
Psychiatry Res. 2014 Dec 15;220(1-2):664-8. doi: 10.1016/j.psychres.2014.07.078. Epub 2014 Aug 8.
4
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].[一种用于评估精神分裂症认知功能的新工具的价值:精神分裂症认知功能简短评估量表(BACS)]
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
5
A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA).一项使用蒙特利尔认知评估量表(MoCA)测量重度精神分裂症患者认知功能损害的初步研究。
Schizophr Res. 2014 Sep;158(1-3):151-5. doi: 10.1016/j.schres.2014.07.006. Epub 2014 Aug 1.
6
Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.在澳大利亚老年病诊所中,快速轻度认知障碍(Qmci)筛查与蒙特利尔认知评估(MoCA)的比较。
Int J Geriatr Psychiatry. 2017 Jun;32(6):643-649. doi: 10.1002/gps.4505. Epub 2016 Jul 18.
7
Montreal Cognitive Assessment (MoCA) and Digit Symbol Substitution Test (DSST) as a screening tool for evaluation of cognitive deficits in schizophrenia.蒙特利尔认知评估量表(MoCA)和数字符号替换测试(DSST)作为一种筛查工具,用于评估精神分裂症患者的认知缺陷。
Psychiatry Res. 2022 Oct;316:114731. doi: 10.1016/j.psychres.2022.114731. Epub 2022 Jul 17.
8
Evaluation of extent and pattern of neurocognitive functions in mild and moderate traumatic brain injury patients by using Montreal Cognitive Assessment (MoCA) score as a screening tool: An observational study from India.采用蒙特利尔认知评估量表(MoCA)评分作为筛查工具评估轻度和中度创伤性脑损伤患者的神经认知功能的程度和模式:来自印度的一项观察性研究。
Asian J Psychiatr. 2019 Mar;41:60-65. doi: 10.1016/j.ajp.2018.08.007. Epub 2018 Aug 10.
9
The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.蒙特利尔认知评估-基础版(MoCA-B)在南非农村地区接受联合抗逆转录病毒治疗的 HIV 患者中,作为认知能力下降的筛查工具并不可靠。
Int J Infect Dis. 2018 Feb;67:36-40. doi: 10.1016/j.ijid.2017.11.024. Epub 2017 Nov 26.
10
Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms.使用 MoCA 或 BRIEF-A 测量患有多种物质使用障碍的年轻成年人的认知障碍 - 精神症状的意义。
J Subst Abuse Treat. 2019 Feb;97:21-27. doi: 10.1016/j.jsat.2018.11.010. Epub 2018 Nov 22.

引用本文的文献

1
Effectiveness of Adding Metacognitive Training to Occupational Therapy in Patients With Schizophrenia Under Long-Term Hospitalization: A Pilot Randomized Controlled Trial.对长期住院的精神分裂症患者在职业治疗中增加元认知训练的效果:一项初步随机对照试验
Cureus. 2025 Jul 21;17(7):e88476. doi: 10.7759/cureus.88476. eCollection 2025 Jul.
2
Evaluation of the effectiveness of multi-task cognitive activation therapy combining motor and cognitive tasks in patients with schizophrenia.评估多任务认知激活疗法(结合运动和认知任务)对精神分裂症患者的有效性。
PCN Rep. 2025 Jun 10;4(2):e70137. doi: 10.1002/pcn5.70137. eCollection 2025 Jun.
3
Cognitive impairment and associated factors among patients with mood disorders receiving care at public hospitals in Gedeo zone, Southern Ethiopia.
埃塞俄比亚南部盖德奥地区公立医院中接受治疗的情绪障碍患者的认知障碍及相关因素
Soc Psychiatry Psychiatr Epidemiol. 2025 May 29. doi: 10.1007/s00127-025-02932-1.
4
Smoking prevalence and correlates among inpatients with schizophrenia or schizoaffective disorder.精神分裂症或分裂情感性障碍住院患者的吸烟率及其相关因素。
Sci Rep. 2025 May 27;15(1):18508. doi: 10.1038/s41598-025-93256-2.
5
Enhanced computerized cognitive remediation therapy improved cognitive function, negative symptoms, and GDNF in male long-term inpatients with schizophrenia.强化计算机化认知康复治疗改善了男性精神分裂症长期住院患者的认知功能、阴性症状和胶质细胞源性神经营养因子水平。
Front Psychiatry. 2025 Jan 16;15:1477285. doi: 10.3389/fpsyt.2024.1477285. eCollection 2024.
6
Exploring the Implementation of Cognitive Screening in First-Episode Psychosis Settings: The CogScreen Implementation Study.探索在首发精神病环境中实施认知筛查:CogScreen实施研究
Early Interv Psychiatry. 2025 Feb;19(2):e70004. doi: 10.1111/eip.70004.
7
A Comparative Study of Frontal and Cerebellar Lobe Volumes Between Patients With First-Episode Schizophrenia and Healthy Controls and Its Association With Psychopathology and Neurological Soft Signs in Patients.首发精神分裂症患者与健康对照者额叶和小脑叶体积的比较研究及其与患者精神病理学和神经学软体征的关联
Cureus. 2024 Oct 13;16(10):e71389. doi: 10.7759/cureus.71389. eCollection 2024 Oct.
8
Correlations between nutritional indicators and cognitive function in patients with stable schizophrenia in a hospital setting.医院环境中稳定精神分裂症患者营养指标与认知功能的相关性。
PLoS One. 2024 Nov 4;19(11):e0312227. doi: 10.1371/journal.pone.0312227. eCollection 2024.
9
Circulating Cell-Free Mitochondrial DNA in Plasma of Individuals with Schizophrenia and Cognitive Deficit in Mexican Population.墨西哥人群中精神分裂症和认知缺陷个体血浆中的循环游离线粒体DNA
Neuropsychiatr Dis Treat. 2024 Sep 21;20:1757-1765. doi: 10.2147/NDT.S460554. eCollection 2024.
10
Cumulative Effect of Psychosis and Aging on Cognitive Function in Patients Diagnosed With Schizophrenia Spectrum Disorders: A Cognitive Domain Approach.精神分裂症谱系障碍患者中精神病与衰老对认知功能的累积影响:一种认知领域方法
Cureus. 2024 Aug 12;16(8):e66733. doi: 10.7759/cureus.66733. eCollection 2024 Aug.